China Shineway Pharmaceutical Group Limited (CSWYY)
USD 18.53
(0.0%)
USD 18.53
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.51 Billion | 586.69 Million | 499.82 Million | 384.75 Million | 391.61 Million | 388.42 Million |
| Cost of Revenue | 1.12 Billion | 150.33 Million | 126.09 Million | 96.75 Million | 104.84 Million | 104.9 Million |
| Gross Profit | 3.39 Billion | 436.35 Million | 373.73 Million | 288 Million | 286.77 Million | 283.51 Million |
| Operating Expenses | 2.41 Billion | 330.38 Million | 290.87 Million | 226.8 Million | 218.4 Million | 208.56 Million |
| Selling, General and Administrative Expenses | 2.3 Billion | 312.94 Million | 273.4 Million | 212.35 Million | 203.53 Million | 189.19 Million |
| Research and Development Expenses | 110.46 Million | 17.44 Million | 17.47 Million | 14.44 Million | 14.86 Million | 19.36 Million |
| Other Expenses | - | 104.98 Million | 82.85 Million | 86.16 Million | 86.14 Million | 38.77 Million |
| Cost and Expenses | 3.54 Billion | 480.72 Million | 416.96 Million | 323.56 Million | 323.24 Million | 313.46 Million |
| Operating Income | 975.53 Million | 105.97 Million | 82.85 Million | 61.19 Million | 68.37 Million | 74.95 Million |
| Interest Expense | 2.73 Million | 93.55 Thousand | 194.43 Thousand | 2.4 Million | 384.66 Thousand | - |
| Income Tax Expense | 270.74 Million | 28.84 Million | 25.34 Million | 14.48 Million | 20.2 Million | 24.67 Million |
| Earnings before Tax | 1.24 Billion | 136.18 Million | 111.65 Million | 57.23 Million | 93.02 Million | 101.12 Million |
| Net Income | 969.51 Million | 107.33 Million | 86.31 Million | 42.74 Million | 72.81 Million | 76.45 Million |
| Earnings Per Share Basic | 1.28 | 2.84 | 2.29 | 1.13 | 1.87 | 1.87 |
| Earnings Per Share Diluted | 1.28 | 2.84 | 2.29 | 1.13 | 1.86 | 1.87 |
| Weighted Average Shares Outstanding | 755.4 Million | 37.77 Million | 37.75 Million | 37.83 Million | 39.04 Million | 40.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 755.4 Million | 37.77 Million | 37.75 Million | 37.83 Million | 39.04 Million | 40.89 Million |
| Gross Margin | 0.75 | 0.74 | 0.75 | 0.75 | 0.73 | 0.73 |
| EBIT Margin | 0.31 | 0.20 | 0.19 | 0.18 | 0.19 | 0.21 |
| Profit Margin | 0.21 | 0.18 | 0.17 | 0.11 | 0.19 | 0.20 |
| EBITDA | 1.42 Billion | 114.68 Million | 92.72 Million | 620.03 Million | 76.09 Million | 81.13 Million |
| Earnings Before Tax Margin | 0.22 | 0.18 | 0.17 | 0.16 | 0.17 | 0.19 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 289.18 Million | 637.47 Million | 292.61 Million | 346.07 Million | 305.81 Million | 586.69 Million |
| Cost of Revenue | 71.3 Million | 158.42 Million | 72.9 Million | 85.8 Million | 74.74 Million | 150.33 Million |
| Gross Profit | 217.88 Million | 479.05 Million | 219.7 Million | 260.27 Million | 231.06 Million | 436.35 Million |
| Operating Expenses | 140.19 Million | 342.13 Million | 166.63 Million | 175.72 Million | 177.84 Million | 330.38 Million |
| Selling, General and Administrative Expenses | 133.99 Million | - | 158.03 Million | 168.76 Million | 165.13 Million | - |
| Research and Development Expenses | 6.2 Million | - | 8.6 Million | 6.95 Million | 12.71 Million | - |
| Other Expenses | - | - | - | - | - | 104.98 Million |
| Cost and Expenses | 211.5 Million | 500.55 Million | 239.54 Million | 261.52 Million | 252.59 Million | 480.72 Million |
| Operating Income | 77.68 Million | 136.92 Million | 53.06 Million | 84.54 Million | 53.22 Million | 105.97 Million |
| Interest Expense | 395.24 Thousand | 2.73 Million | 354.52 Thousand | 24.67 Thousand | 40.81 Thousand | 93.55 Thousand |
| Income Tax Expense | 32.65 Million | 38.21 Million | 12.56 Million | 25.94 Million | 16.32 Million | 28.84 Million |
| Earnings before Tax | 119.47 Million | 175.05 Million | 78.61 Million | 96.85 Million | 72.4 Million | 136.18 Million |
| Net Income | 86.82 Million | 136.83 Million | 66.04 Million | 70.9 Million | 56.08 Million | 107.33 Million |
| Earnings Per Share Basic | 2.30 | - | 1.75 | 1.88 | 1.49 | - |
| Earnings Per Share Diluted | 2.30 | - | 1.75 | 1.88 | 1.49 | - |
| Weighted Average Shares Outstanding | 37.77 Million | 37.77 Million | 37.77 Million | 37.77 Million | 37.77 Million | 37.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.77 Million | 37.77 Million | 37.77 Million | 37.77 Million | 37.77 Million | 37.77 Million |
| Gross Margin | 0.75 | 0.75 | 0.75 | 0.75 | 0.76 | 0.74 |
| EBIT Margin | 0.27 | - | 0.22 | 0.28 | 0.22 | - |
| Profit Margin | 0.30 | 0.21 | 0.23 | 0.20 | 0.18 | 0.18 |
| EBITDA | 77.68 Million | - | 65.64 Million | 96.97 Million | 66.39 Million | - |
| Earnings Before Tax Margin | 0.27 | 0.21 | 0.18 | 0.24 | 0.17 | 0.18 |
INDFY
267850
FQT
5548
MIN
0YC0